Valiant Laboratories Cash Flow Statement

Financials in millions INR. Fiscal year is April - March.

Millions INR. Fiscal year is Apr - Mar.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022
Period Ending	Sep '24 Sep 30, 2024	Mar '24 Mar 31, 2024	Mar '23 Mar 31, 2023	Mar '22 Mar 31, 2022
Net Income	-99.93	3.2	289.98	340.74
Depreciation & Amortization	20.67	19.66	15.63	24.26
Loss (Gain) From Sale of Assets	-0.05	-	-	-0.59
Other Operating Activities	41.19	-0.3	3.31	-10.28
Change in Accounts Receivable	412.06	428.41	222.01	-791.1
Change in Inventory	181.09	30.27	27.62	21.15
Change in Accounts Payable	-402.37	-213.69	80.24	480.6
Change in Other Net Operating Assets	8.05	-248.69	-78.28	72.9
Operating Cash Flow	162.08	18.85	560.51	137.68
Operating Cash Flow Growth	12.99%	-96.64%	307.12%	-
Capital Expenditures	-1,039	-458.7	-376.81	-88.2
Sale of Property, Plant & Equipment	0.14	-	-	0.59
Investment in Securities	-808.52	-980.07	-136.97	-
Other Investing Activities	-199.06	-	-37.91	-143.25
Investing Cash Flow	-2,046	-1,439	-551.68	-230.85
Short-Term Debt Issued	-	13.88	-	-
Long-Term Debt Issued	-	152.63	3.72	-
Total Debt Issued	548.79	166.5	3.72	19.21
Short-Term Debt Repaid	-	-	-12.81	-
Total Debt Repaid	-	-	-12.81	-440.25
Net Debt Issued (Repaid)	548.79	166.5	-9.09	-421.04
Issuance of Common Stock	1,359	1,359	-	733.49
Other Financing Activities	-0.98	-0.78	-0.25	-0.88
Financing Cash Flow	1,907	1,524	-9.34	311.57
Miscellaneous Cash Flow Adjustments	-0	-	-	0
Net Cash Flow	22.36	104.57	-0.51	218.39
Free Cash Flow	-876.78	-439.85	183.7	49.48
Free Cash Flow Growth	-	-	271.26%	-
Free Cash Flow Margin	-78.66%	-24.16%	5.50%	1.58%
Free Cash Flow Per Share	-20.19	-11.57	5.64	1.52
Cash Interest Paid	0.98	0.78	0.25	0.36
Cash Income Tax Paid	-	-9.82	88	115.88
Levered Free Cash Flow	-1,116	-400.31	290.4	-
Unlevered Free Cash Flow	-1,115	-399.83	291.98	-
Change in Net Working Capital	-41.01	-104.05	-443.62	-

Source: S&P Capital IQ. Standard template. Financial Sources.